A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.
about
Astatine Radiopharmaceuticals: Prospects and ProblemsExperimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab.Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.A proposed methodology to select radioisotopes for use in radionuclide therapy.
P2860
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A limiting factor for the prog ...... ity of suitable radionuclides.
@ast
A limiting factor for the prog ...... ity of suitable radionuclides.
@en
type
label
A limiting factor for the prog ...... ity of suitable radionuclides.
@ast
A limiting factor for the prog ...... ity of suitable radionuclides.
@en
prefLabel
A limiting factor for the prog ...... ity of suitable radionuclides.
@ast
A limiting factor for the prog ...... ity of suitable radionuclides.
@en
P2860
P1433
P1476
A limiting factor for the prog ...... lity of suitable radionuclides
@en
P2093
Hans Lundqvist
Jörgen Carlsson
P2860
P304
P356
10.1080/02841860410028943
P577
2004-01-01T00:00:00Z